目錄:愛必信(上海)生物科技有限公司>>生化試劑>>小分子化合物>> abs810001aLY 294002
參考價 | ¥215-¥1105 |
參考價:¥215 ~ ¥1105
10mg 25mg 100mg
CAS:154447-36-6 純度:>98% 分子量:- 分子式:- 供貨周期:現貨 規格:10mg;25mg;100mg 貨號:abs810001 應用領域:生物產業,綜合 主要用途:-
>10mg | 215元 | 999件可售 |
25mg | 385元 | 999件可售 |
100mg | 1105元 | 999件可售 |
更新時間:2024-10-28 09:14:50瀏覽次數:1223評價
聯系我們時請說明是化工儀器網上看到的信息,謝謝!
CAS | 154447-36-6 | 純度 | >98% |
---|---|---|---|
分子量 | - | 分子式 | - |
供貨周期 | 現貨 | 規格 | 10mg;25mg;100mg |
貨號 | abs810001 | 應用領域 | 生物產業,綜合 |
主要用途 | - |
產品描述 | |
描述 | LY 294002是已知抑制PI3Kα/δ/β的小分子,在無細胞測定中IC50分別為 0.5μM/0.57 μM/0.97μM;在溶液中比在Wortmannin中穩定,也能夠阻斷自噬體的形成。
|
純度 | >98% |
儲存/保存方法 | Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution. |
基本信息 | |
別名 | NSC 697286; SF 1101; LY 294002; LY-294002 |
外觀 | white to off-white powder |
可溶性/溶解性 | DMSO:36 mg/mL (117.13 mM) Ethanol:21 mg/mL (68.32 mM) |
生物活性 | |
靶點 | p110α,p110δ,p110β,DNA-PK |
In vitro(體外研究) | LY294002 is not exclusively selective for the PI3Ks, and could in fact act on other lipid kinases and additional apparently unrelated proteins. LY294002 is shown to inhibit not only mTOR and DNA-PK, but also other protein kinases, such as CK2 (casein kinase 2) and Pim-1. LY294002 inactivates Akt/PKB, consequently inhibiting cell proliferation and inducing apoptosis. LY294002 demonstrates a remarkable growth-inhibitory and apoptosis-inducing effect in these colon cancer cell lines, with decreased expression of phosphorylated Akt (Ser473). LY294002 induces marked nuclear pyknosis and diminished cytoplasmic volume in the tumor cells. Thus, LY294002 markedly inhibits ovarian cancer cell proliferation in vitro. LY294002 induces specific G1 arrest in cell growth, leading to almost complete inhibition of melanoma cell proliferation and partial inhibition of MG-63 (osteosarcoma cell line) proliferation. The effect of LY294002 on cell cycle progression may provide insights into a possible link between the PI3K activation pathway and cancer cell cycle regulation. |
In vivo(體內研究) | LY294002 also results in suppression of tumor growth and induction of apoptosis, especially in the LoVo tumors, and therefore shows remarkable effectiveness in the mouse peritonitis carcinomatosa model. LY294002 significantly inhibits growth and ascites formation of ovarian carcinoma. |
參考文獻 | |
參考文獻 | [1] Chaussade C, et al. Biochem J, 2007, 404(3), 449-58. [2] Semba S, et al. Clin Cancer Res, 2002, 8(6), 1957-63. [3] Hu L, et al. Clin Cancer Res, 2000, 6(3), 880-6. |